Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice.

Smart Nanotransformers with Unique Enzyme-Inducible Structural Changes and Drug Release Properties. Biomacromolecules (2016) 0.75

Enzymatic self-assembly of an immunoreceptor tyrosine-based inhibitory motif (ITIM). Org Biomol Chem (2017) 0.75

Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol (2003) 6.57

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science (1998) 3.46

Self-assembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair. Proc Natl Acad Sci U S A (2002) 3.29

B-cell memory is short-lived in the absence of antigen. Nature (1988) 2.57

Self-complementary oligopeptide matrices support mammalian cell attachment. Biomaterials (1995) 2.40

Induction of secretory immunity and memory at mucosal surfaces. Vaccine (2006) 2.24

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine (2000) 1.71

Biological designer self-assembling peptide nanofiber scaffolds significantly enhance osteoblast proliferation, differentiation and 3-D migration. PLoS One (2007) 1.67

A self-assembling peptide acting as an immune adjuvant. Proc Natl Acad Sci U S A (2009) 1.62

A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS One (2010) 1.57

Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine (2005) 1.51

Alum adjuvanticity: unraveling a century old mystery. Eur J Immunol (2008) 1.27

GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults. J Infect Dis (2011) 1.22

Dissolving microneedle patch for transdermal delivery of human growth hormone. Small (2011) 1.17

Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice. Virology (2012) 1.16

Adjuvant solution for pandemic influenza vaccine production. Proc Natl Acad Sci U S A (2012) 1.14

Dental pulp tissue engineering in full-length human root canals. J Dent Res (2013) 1.13

Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials (2012) 0.99

Determination of the in vivo degradation mechanism of PEGDA hydrogels. J Biomed Mater Res A (2014) 0.97

Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice. J Virol (2012) 0.97

Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels. Acta Biomater (2014) 0.93

Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem. Nat Immunol (2014) 0.90

Virus-like particle vaccine containing hemagglutinin confers protection against 2009 H1N1 pandemic influenza. Clin Vaccine Immunol (2011) 0.90

Antigenic peptide nanofibers elicit adjuvant-free CD8⁺ T cell responses. Vaccine (2013) 0.90

Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease. PLoS One (2013) 0.87

Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge. Hum Vaccin Immunother (2012) 0.87

Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes. Vaccine (2011) 0.87

Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants. Braz J Med Biol Res (2011) 0.86

Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice. Vaccine (2011) 0.85

The bioactivity of agarose-PEGDA interpenetrating network hydrogels with covalently immobilized RGD peptides and physically entrapped aggrecan. Biomaterials (2014) 0.85

Adjuvanted influenza vaccines. Hum Vaccin Immunother (2012) 0.83

Compartmentalized multilayer hydrogel formation using a stimulus-responsive self-assembling polysaccharide. ACS Appl Mater Interfaces (2014) 0.83

A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS). II. Studies in mice and ferrets and mechanism of adjuvanticity. Vaccine (2011) 0.82

Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice. PLoS One (2012) 0.82

Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus. Diabet Med (2011) 0.82

Controlled release of insulin from self-assembling nanofiber hydrogel, PuraMatrix™: application for the subcutaneous injection in rats. Eur J Pharm Sci (2011) 0.81

Investigation of different cell types and gel carriers for cell-based intervertebral disc therapy, in vitro and in vivo studies. J Tissue Eng Regen Med (2011) 0.80

A preliminary study of the dental implant therapy--initial osteogenesis of human mesenchymal stem (HMS0014) cells on titanium discs with different surface modifications. Okajimas Folia Anat Jpn (2012) 0.80

Developments of subunit and VLP vaccines against influenza A virus. Virol Sin (2012) 0.78

Management of peritoneal effusion by sealing with a self-assembling nanofiber polypeptide following pelvic surgery. Hepatogastroenterology (2014) 0.76